Cargando…

A Pilot Dose‐Finding Study of Etanercept in Rheumatoid Arthritis

A randomized, parallel‐dose study assessed the pharmacokinetics (PK) and pharmacodynamics (PD) of etanercept in 61 patients with rheumatoid arthritis (RA) who received doses from 10 mg once‐weekly to 50 mg twice‐weekly for 4 weeks. Empiric application of a maximal‐effect (E(max)) model to pooled ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Breedveld, Ferdinand C., Jones, Heather E., Peifer, Kim, Korth‐Bradley, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759732/ https://www.ncbi.nlm.nih.gov/pubmed/28892591 http://dx.doi.org/10.1111/cts.12502

Ejemplares similares

Optimal dose of etanercept in the treatment of rheumatoid arthritis
por: Curtis, Elizabeth Mary, et al.
Publicado: (2014)

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
por: van Vollenhoven, Ronald F, et al.
Publicado: (2016)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Current and future management approaches for rheumatoid arthritis
por: Breedveld, Ferdinand C
Publicado: (2002)

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2012)

Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Lurati, Alfredomaria, et al.
Publicado: (2010)

The adjuvant use of calcium fructoborate and borax with etanercept in patients with rheumatoid arthritis: Pilot study
por: Hussain, Saad Abdulrahman, et al.
Publicado: (2016)

Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study
por: Mahmood, Naza Mohammed Ali, et al.
Publicado: (2018)

Understanding emerging treatment paradigms in rheumatoid arthritis
por: Breedveld, Ferdinand C, et al.
Publicado: (2011)

A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis
por: Polák, Pavol, et al.
Publicado: (2019)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
por: Chadwick, Laura, et al.
Publicado: (2018)

The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis
por: Incerti, Devin, et al.
Publicado: (2020)

Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
por: Kang, Min-Jung, et al.
Publicado: (2007)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
por: Cao, Jian, et al.
Publicado: (2019)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
por: BOSKOVIC, OLIVERA, et al.
Publicado: (2020)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
por: Chen, Hsin-Hua, et al.
Publicado: (2016)

Markers in rheumatoid arthritis
por: Breedveld, FC
Publicado: (2004)

Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali(®)) Versus Etanercept (Enbrel(®)) - Findings from a Nurse Survey in Europe
por: Thakur, Kunal, et al.
Publicado: (2016)

Redox Balance Alterations and Hyporesponsiveness of Synovial T Cells in Rheumatoid Arthritis
por: Breedveld, Ferdinand C, et al.
Publicado: (2000)

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
por: Koike, Takao, et al.
Publicado: (2011)

Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
por: Kang, Min-Jung, et al.
Publicado: (2006)

Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis
por: Durel, Cécile-Audrey, et al.
Publicado: (2013)

Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
por: Echeverri, Andrés F., et al.
Publicado: (2015)

Alopecia Universalis in a Case of Rheumatoid Arthritis after Treatment with Etanercept
por: Kandpal, Renu
Publicado: (2019)

Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis
por: Plant, Darren, et al.
Publicado: (2016)

Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
por: Akhlaghi, Saeed, et al.
Publicado: (2019)

Dermatomyositis–lupuslike syndrome overlap under treatment with etanercept for rheumatoid arthritis
por: Lyakhovitsky, Anna, et al.
Publicado: (2020)

Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe
por: Thakur, Kunal, et al.
Publicado: (2016)

Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2023)

Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
por: Smolen, Josef S., et al.
Publicado: (2018)

Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
por: Catrina, AI, et al.
Publicado: (2003)

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up
por: Vogelzang, E. H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8t2352us123s18oro04mlq84bh